Applied Biomedical Technology

Abstract

For the Guidance for Development of the Force - Applied Biomedical Technology: This applied research funding is to refine concepts and ideas into potential solutions to military health and performance problems, with a view towards evaluating technical feasibility. Included are studies and investigations leading to candidate solutions that may involve use of animal models for testing in preparation for initial human testing. Research in this program element is designed to address the following: areas of interest to the Secretary of Defense regarding Wounded Warriors, capabilities identified through the Joint Capabilities Integration and Development System, and the strategy and initiatives described in the Quadrennial Defense Review. Program development is peer-reviewed and fully coordinated with all Military Services, appropriate Defense Agencies or Activities, and other federal agencies, to include the Department of Veterans Affairs, the Department of Health and Human Services, and the Department of Homeland Security. This coordination occurs through the planning and execution activities of the Joint Program Committees, established for the Defense Health Program Research, Development, Test and Evaluation (RDT&E) funding. Research supported by this program element includes polytrauma and blast injury, rehabilitation, diagnosis and treatment of brain injury, operational health and performance, radiation countermeasures, and psychological health and well-being for military personnel and families. For the Army Medical Command, beginning in FY14, the military HIV research program funding is transferred from the Army to the Defense Health Program. HIV causes acquired immunodeficiency syndrome (AIDS). Work in this area includes refining improved identification methods to determine genetic diversity of the virus, preclinical work in laboratory animals including non-human primates to identify candidates for future vaccine refinement, and evaluating and preparing overseas sites for future vaccine trials. The Army Medical Command also received DHP Congressional Special Interest (CSI) research funding focused on Peer-Reviewed Traumatic Brain Injury and Psychological Health Research, and Peer-Reviewed Hemorrhage (bleeding) Control Research. Because of the CSI annual structure, out-year funding is not programmed. For the Air Force, this PE funds applied research which seeks to promote ‘omic’-informed personalized medicine with an emphasis on targeted prevention, diagnosis, and treatment. The delivery of pro-active, evidence-based, personalized medicine will improve health in Warfighters and beneficiaries by providing care that is specific to the situation and patient, to include preventing disease or injury, early and accurate diagnosis, and selection of appropriate and effective treatment. Personalized medicine will reduce morbidity, mortality, mission impact of illness/injury, and healthcare costs while increasing health and wellness of the AF population and efficiency of the healthcare system. This applied research supports multiple focus areas, each of which represents an identified barrier/gap which must be addressed for successful implementation of ‘omic-informed personalized medicine. Focus areas for applied research include knowledge generation research; ethical legal and social issues/policy research; bioinformatics research; educational research; research for development of advanced genomic diagnostic system. For efforts supported by this program element, research will be pursued with the intent to support solutions that answer Air Force specific needs. During this process, the efforts of other government agencies in those areas will be assessed to avoid redundancy.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2014
Source ID
0602115HP_2_0130_PB_2014
Change Summary Explanation
FY 2012: Restore FY 2013 President’s Budget decrease to Congressional Special Interest from DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) Program (-$0.869 million) to DHP RDT&E, PE 0602115- Applied Biomedical Technology (+$0.869 million). Realignment from DHP RDT&E, PE 0602115-Applied Biomedical Technology (-$0.550 million) to DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) Program (+$0.550 million). FY 2013: No Change FY 2014: Change Proposal increase to DHP RDT&E, PE 0602115-Applied Biomedical Technology (+$8.976 million) for the Military HIV Research Program (MHRP) from RDT&E, Army, appropriation.
Service Agency Name
Defense Health Program

Tags

DTIC Thesaurus Topics

  • Biomedical Technology
  • Brain Injuries
  • Casualties
  • Combat Casualty Care
  • Diseases And Disorders
  • Drug Therapy
  • Families (Human)
  • Infectious Diseases
  • Injury Prevention
  • Medical Personnel
  • Military Personnel
  • Operations Research
  • Pain Management
  • Test And Evaluation
  • Traumatic Stress Disorder
  • Wound Infections
  • Wounds And Injuries

Fields of Study

  • Medicine

Readers

  • Infectious Disease/Epidemiology
  • Medical or Health Care Field.
  • Military Science and Technology Research and Modernization.

Technology Areas

  • Biotechnology

Related Documents